摘要 |
The invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof, wherein X<SUB>1</SUB>, X<SUB>2 </SUB>and X<SUB>3 </SUB>are each independently where Y is an alkylene, alkenylene or alkynylene group, each of which may be optionally substituted with one or more substituents selected from alkyl, halo, CF<SUB>3</SUB>, OH, alkoxy, NH<SUB>2</SUB>, CN, NO<SUB>2 </SUB>and COOH; W is absent or is O, S or NH; R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3 </SUB>and R<SUB>4 </SUB>are each independently selected from H, alkyl, aryl and a protecting group P<SUB>1</SUB>; R<SUB>7</SUB>, R<SUB>8 </SUB>and R<SUB>9 </SUB>are each independently selected from H, alkyl, halo, CF<SUB>3</SUB>, OH, alkoxy, NH<SUB>2</SUB>, CN, NO<SUB>2 </SUB>and COOH; q and r are each independently 1, 2, 3 or 4; q' and r' are each independently 0, 1, 2 or 3, where q+q' and r+r' each equal 4; p is 1, 2, 3, 4 or 5, and p' is 0, 1, 2, 3 or 4, where p+p' is 5; n is 0, 1, 2, 3 . . . 6; L is (Z)<SUB>m</SUB>NR<SUB>5</SUB>R<SUB>6 </SUB>where Z is a hydrocarbyl group and m is 0 or 1; where R<SUB>5 </SUB>and R<SUB>6 </SUB>are each independently H, CO(CH<SUB>2</SUB>)<SUB>j</SUB>Q<SUB>1 </SUB>or C-S(NH)(CH<SUB>2</SUB>)<SUB>k</SUB>Q<SUB>2 </SUB>where j and k are each independently 0, 1, 2, 3, 4 or 5, and Q<SUB>1 </SUB>and Q<SUB>2 </SUB>are each independently selected from COOH, a chromophore or R<SUB>5</SUB>, R<SUB>6 </SUB>and the nitrogen to which they are attached together form
|